Items where Subject is "HER2"

C

Chan, P. M., Nestler, H. P., Miller, W. T. (November 2000) Investigating the substrate specificity of the HER2/Neu tyrosine kinase using peptide libraries. Cancer Letters, 160 (2). pp. 159-169. ISSN 0304-3835

H

Hicks, J. B., McArthur, H., Tan, L. K., Patil, S., Wigler, M. H., Hudis, C., Norton, L. (May 2009) Topo2a and Her2 Co-Amplification Is Uncommon by High Resolution Representational Oligonucleotide Microarray Analysis (Roma) in Human Breast Cancer. Annals of Oncology, 20 (S2). ii22-23. ISSN 0923-7534

M

McArthur, H. L., Brogi, E., Patil, S., Wigler, M. H., Norton, L., Hicks, J. B., Hudis, C. A. (September 2009) High resolution microarray copy number analysis (array CGH) suggests that determination of HER2 amplification by FISH (FISH plus ) is inaccurate in human breast cancer specimens that are HER2 2+by immunohistochemistry (IHC2+). European Journal of Cancer Supplements, 7 (2). p. 88. ISSN 1359-6349

McArthur, H. L., Tan, L. K., Patil, S., Wigler, M. H., Hudis, C. A., Hicks, J. B., Norton, L. (January 2009) High resolution representational oligonucleotide microarray analysis (ROMA) suggests that TOPO2 and HER2 co-amplification is uncommon in human breast cancer. Cancer Res, 69 (2, Sup). 163S-163S. ISSN 0008-5472

W

Wang, S. E., Narasanna, A., Perez-Torres, M., Xiang, B., Wu, F. Y., Yang, S., Carpenter, G., Gazdar, A. F., Muthuswamy, S. K., Arteaga, C. L. (2006) HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell, 10 (1). pp. 25-38. ISSN 15356108